These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. A pilot study of dextromethorphan in naloxone-precipitated opiate withdrawal. Rosen MI; McMahon TJ; Woods SW; Pearsall HR; Kosten TR Eur J Pharmacol; 1996 Jul; 307(3):251-7. PubMed ID: 8836612 [TBL] [Abstract][Full Text] [Related]
7. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats. Stinus L; Cador M; Zorrilla EP; Koob GF Neuropsychopharmacology; 2005 Jan; 30(1):90-8. PubMed ID: 15138444 [TBL] [Abstract][Full Text] [Related]
8. GHB ameliorates naloxone-induced conditioned place aversion and physical aspects of morphine withdrawal in mice. Maldonado C; Rodríguez-Arias M; Aguilar MA; Miñarro J Psychopharmacology (Berl); 2004 Dec; 177(1-2):130-40. PubMed ID: 15179545 [TBL] [Abstract][Full Text] [Related]
9. Increased elevated plus maze open-arm time in mice during naloxone-precipitated morphine withdrawal. Hodgson SR; Hofford RS; Norris CJ; Eitan S Behav Pharmacol; 2008 Dec; 19(8):805-11. PubMed ID: 19020415 [TBL] [Abstract][Full Text] [Related]
10. Evaluation for the withdrawal syndrome from gamma-hydroxybutyric acid (GHB), gamma-butyrolactone (GBL), and 1,4-butanediol (1,4-BD) in different rat lines. Quang LS; Colombo G; Lobina C; Maccioni P; Orru A; Gessa GL; Maher TJ; Carai MA Ann N Y Acad Sci; 2006 Aug; 1074():545-58. PubMed ID: 17105952 [TBL] [Abstract][Full Text] [Related]
11. Dopamine D2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal. Wang GJ; Volkow ND; Fowler JS; Logan J; Abumrad NN; Hitzemann RJ; Pappas NS; Pascani K Neuropsychopharmacology; 1997 Feb; 16(2):174-82. PubMed ID: 9015800 [TBL] [Abstract][Full Text] [Related]
12. The NMDA antagonist dizocilpine (MK801) attenuates motivational as well as somatic aspects of naloxone precipitated opioid withdrawal. Higgins GA; Nguyen P; Sellers EM Life Sci; 1992; 50(21):PL167-72. PubMed ID: 1533700 [TBL] [Abstract][Full Text] [Related]
13. Total neurochemical lesion of noradrenergic neurons of the locus ceruleus does not alter either naloxone-precipitated or spontaneous opiate withdrawal nor does it influence ability of clonidine to reverse opiate withdrawal. Caillé S; Espejo EF; Reneric JP; Cador M; Koob GF; Stinus L J Pharmacol Exp Ther; 1999 Aug; 290(2):881-92. PubMed ID: 10411605 [TBL] [Abstract][Full Text] [Related]
14. Naloxone and metergoline effects on growth hormone response to gamma-hydroxybutyric acid. Gerra G; Caccavari R; Fontanesi B; Fertonani Affini G; Maestri D; Avanzini P; Zaimovic A; Franchini D; Delsignore R Int Clin Psychopharmacol; 1995 Nov; 10(4):245-50. PubMed ID: 8748046 [TBL] [Abstract][Full Text] [Related]
15. Brain reward deficits accompany naloxone-precipitated withdrawal from acute opioid dependence. Liu J; Schulteis G Pharmacol Biochem Behav; 2004 Sep; 79(1):101-8. PubMed ID: 15388289 [TBL] [Abstract][Full Text] [Related]
16. The effect of lamotrigine on naloxone-precipitated opiate withdrawal. Rosen MI; Pearsall HR; Kosten TR Drug Alcohol Depend; 1998 Oct; 52(2):173-6. PubMed ID: 9800147 [TBL] [Abstract][Full Text] [Related]
17. Initial methadone dose in treating opiate addiction. Wang RI; Kochar C; Hasegawa AT; Roh BL Int J Addict; 1982 Feb; 17(2):357-63. PubMed ID: 7076369 [TBL] [Abstract][Full Text] [Related]
18. Plasma malondialdehyde levels and opiate withdrawal signs observed in rats treated with morphine plus naloxone: effects of alpha-lipoic acid administration. Pinelli A; Cighetti G; Trivulzio S Fundam Clin Pharmacol; 2008 Aug; 22(4):439-45. PubMed ID: 18705754 [TBL] [Abstract][Full Text] [Related]
19. A non-invasive gating device for continuous drug delivery that allows control over the timing and duration of spontaneous opiate withdrawal. Azar MR; Ahmed SH; Lintz R; Gutierrez T; Stinus L; Koob GF J Neurosci Methods; 2004 May; 135(1-2):129-35. PubMed ID: 15020097 [TBL] [Abstract][Full Text] [Related]
20. Opiate withdrawal-induced hyposensitivity to naloxone's effects on serum luteinizing hormone in the male rat. Cicero TJ; Aleem A; Meyer ER; Schmoeker PF; Miller BT J Pharmacol Exp Ther; 1986 Sep; 238(3):1063-70. PubMed ID: 3528453 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]